SEC Form 10-Q filed by The Cigna Group

Total revenues for the third quarter 2025 increased 10% to $69.7 billionShareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per shareAdjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2The Cigna Group announced a new rebate-free pharmacy benefit model designed to lower costs, improve transparency, and support local pharmaciesBLOOMFIELD, Conn., Oct. 30, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported third quarter 2025 results that reflect strategic execution across its diverse portfolio of busines

Unveils Transparent Rebate-Free Pharmacy Benefit; Lower Costs and Better Experience for Americans; Greater Support for Local Pharmacies BLOOMFIELD, Conn., Oct. 27, 2025 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help Americans stay healthy and get the medications they need by lowering costs, improving transparency, and supporting local pharmacies so care is always within reach. "While pharmacy benefit managers have already helped the U.S. achieve the lowest prices for

BLOOMFIELD, Conn., Oct. 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and ser

Goldman initiated coverage of The Cigna Group with a rating of Buy and set a new price target of $370.00

Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

4 - Cigna Group (0001739940) (Issuer)

Total revenues for the third quarter 2025 increased 10% to $69.7 billionShareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per shareAdjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2The Cigna Group announced a new rebate-free pharmacy benefit model designed to lower costs, improve transparency, and support local pharmaciesBLOOMFIELD, Conn., Oct. 30, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported third quarter 2025 results that reflect strategic execution across its diverse portfolio of busines

BLOOMFIELD, Conn., Oct. 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and ser

BLOOMFIELD, Conn., Oct. 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2025 financial results on Thursday, October 30, 2025, and will host a conference call the same day. Third quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:                Live Call               (888) 566-1889 (Domestic)               (773) 799-3989 (International)               Passcode: 1030

BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

SC 13G - Cigna Group (0001739940) (Subject)

SC 13G/A - Cigna Group (0001739940) (Subject)

SC 13G/A - Cigna Group (0001739940) (Subject)